WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...
Therefore, quantifying hepatic fat content is crucial for early diagnosis and disease management. This article summarizes advances in imaging techniques for assessing hepatic steatosis, with a focus ...
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care Achieved Intraclass ...
Feasibility study data at 12-22% liver fat cutoffs validate TAEUS as a potential low-cost, point-of-care alternative to MRI-PDFF for patient stratification and trial monitoring ANN ARBOR, ...
Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...
Approximately a third of the adult population worldwide has MASLD, the presence of steatosis (the accumulation of fat) in the ...
PET-CT imaging with [18 F]fluorodeoxyglucose (FDG) and [18 F]fluorocholine (FCH) altered treatment plans in only a tiny minority of patients undergoing initial staging for hepatocellular carcinoma ...
ENDRA Life Sciences NDRA recently announced positive findings from a clinical study assessing the measurement consistency of its TAEUS Liver device. The evaluation demonstrated strong intra-operator ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results